The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review

CNS Drugs
J PeuskensMarc De Hert

Abstract

Since the 1970s, clinicians have increasingly become more familiar with hyperprolactinemia (HPRL) as a common adverse effect of antipsychotic medication, which remains the cornerstone of pharmacological treatment for patients with schizophrenia. Although treatment with second-generation antipsychotics (SGAs) as a group is, compared with use of the first-generation antipsychotics, associated with lower prolactin (PRL) plasma levels, the detailed effects on plasma PRL levels for each of these compounds in reports often remain incomplete or inaccurate. Moreover, at this moment, no review has been published about the effect of the newly approved antipsychotics asenapine, iloperidone and lurasidone on PRL levels. The objective of this review is to describe PRL physiology; PRL measurement; diagnosis, causes, consequences and mechanisms of HPRL; incidence figures of (new-onset) HPRL with SGAs and newly approved antipsychotics in adolescent and adult patients; and revisit lingering questions regarding this hormone. A literature search, using the MEDLINE database (1966-December 2013), was conducted to identify relevant publications to report on the state of the art of HPRL and to summarize the available evidence with respect to the prop...Continue Reading

References

Sep 23, 2014·Expert Opinion on Emerging Drugs·Luisa-Sophie KösterChristoph U Correll
Jan 31, 2015·Expert Opinion on Investigational Drugs·Mauro Giovanni CartaJoseph R Calabrese
Dec 4, 2015·Psychiatry Research·Benjamin I PerrySharmila J Menon
Mar 12, 2016·Gynécologie, obstétrique & fertilité·A-C PaepegaeyS Christin-Maitre
Jan 16, 2016·Oxidative Medicine and Cellular Longevity·Hugo Juárez OlguínGerardo Barragán Mejía
Nov 21, 2015·Endocrinology, Diabetes & Metabolism Case Reports·Lisa Burback
Oct 8, 2015·Biological Psychiatry·Jeffrey A LiebermanKimberly E Vanover
May 25, 2016·The Psychiatric Clinics of North America·Donna AmesLynn M Yudofsky
Jun 5, 2015·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Christoph U CorrellMarc De Hert
Jul 22, 2014·Acta Psychiatrica Scandinavica·Brendon StubbsDavy Vancampfort
Jun 20, 2015·Journal of Child and Adolescent Psychopharmacology·Robert L FindlingMaju Mathews
Jun 27, 2015·Expert Opinion on Pharmacotherapy·Dawn BruijnzeelRajiv Tandon
May 6, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Isabella PacchiarottiEduard Vieta
Feb 11, 2015·General Hospital Psychiatry·Brendon StubbsDavy Vancampfort
Mar 2, 2016·Revista de psiquiatrí́a y salud mental·Ángel L MontejoEduard Vieta
Jun 21, 2016·Journal of the American Geriatrics Society·Marit S BakkenSabine Ruths
Jun 23, 2016·Psychoneuroendocrinology·Itaru MiuraChristoph U Correll
Sep 23, 2016·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Svetlana A IvanovaAnton J M Loonen
Dec 6, 2016·Expert Review of Neurotherapeutics·Hugo GeertsPatrick Roberts
Nov 8, 2017·Journal of Child and Adolescent Psychopharmacology·Chadi A CalargeJanet A Schlechte
Jan 11, 2018·Evidence-based Complementary and Alternative Medicine : ECAM·Ping YangXuejun Liu
Jan 16, 2018·International Journal of Psychiatry in Clinical Practice·Fahad D AlosaimiMohammed Z Alassiry
Mar 9, 2019·International Journal of Psychiatry in Clinical Practice·José María Bonete LlácerBegoña Richart Albelda
Dec 19, 2019·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·A A Portnova, Yu P Sivolap
Mar 19, 2020·The Annals of Pharmacotherapy·Satoshi YokoyamaMitsutaka Takada
Jul 3, 2020·Journal of Child and Adolescent Psychopharmacology·Timothy R Rice, Andreas Walther
Jun 20, 2020·Journal of Clinical Psychopharmacology·James R AgapoffVictor Huynh
May 9, 2020·Human Psychopharmacology·Olga Yu FedorenkoSvetlana A Ivanova
Aug 25, 2020·BMC Cancer·Blánaid M HicksChris R Cardwell
Aug 17, 2019·Frontiers in Pharmacology·Pedro Cabral BarataTeresa Maia

Citations

Nov 1, 1978·Archives of General Psychiatry·P M SchyveH Y Meltzer
Mar 1, 1976·Archives of General Psychiatry·H Y Meltzer, V S Fang
Sep 1, 1992·Clinical and Experimental Pharmacology & Physiology·A KuruvillaA S Kanagasabapathy
Aug 1, 1988·Psychiatry Research·P J BrownB Szechtman
Oct 1, 1987·The American Journal of Psychiatry·N A KeksB S Singh
Oct 1, 1974·Archives of General Psychiatry·H Y MeltzerA G Frantz
Dec 1, 1981·Psychiatry Research·W A Brown, T P Laughren
Jan 1, 1996·Behavioural Brain Research·L D Van de KarA D Levy
Feb 1, 1996·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·C M BeasleyS H Hamilton
Apr 15, 1997·Biological Psychiatry·C M MazureM B Bowers
May 1, 1997·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·C M BeasleyJ N Beuzen
Nov 14, 1997·Acta Psychiatrica Scandinavica·J Peuskens, C G Link
Apr 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·T Y ChunJ Gorski
May 8, 1998·Obstetrics and Gynecology·M SpitzerF Benjamin
Jul 2, 1998·Epidemiology·H Jacqmin-GaddaJ F Dartigues
Jan 23, 1999·Biological Psychiatry·G GründerO Benkert
Feb 6, 1999·Journal of Clinical Psychopharmacology·D L KleinbergM Brecher
Apr 6, 1999·Schizophrenia Research·R G Petty
Apr 6, 1999·Schizophrenia Research·R A Dickson, W M Glazer
Apr 15, 1999·Journal of the National Cancer Institute·S E HankinsonF E Speizer
Aug 6, 1999·Journal of the American Academy of Child and Adolescent Psychiatry·J A FrazierS Shapiro
Oct 16, 1999·American Journal of Epidemiology·J P KellyS Shapiro
Jan 12, 2000·Journal of Child and Adolescent Psychopharmacology·M WudarskyJ L Rapoport
Mar 8, 2000·Experimental Gerontology·M LloveraV Goffin
Mar 14, 2000·Journal of the American Academy of Child and Adolescent Psychiatry·F R SalleeP B Chappell
Oct 4, 2000·Physiological Reviews·M E FreemanG Nagy

Related Concepts

PRL
Amisulpride
Antipsychotic Effect
Blood - Brain Barrier Anatomy
Olanzapine
Pituitary Hormones, Anterior
Schizophrenia
Paliperidone
Clozapine
Ziprasidone

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.